European Journal of Chemistry

A validated stability indicating HPLC method for determination of sitagliptin



Main Article Content

Ola Ahmed Saleh
Aida Abd El-Sattar El-Azzouny
Hassan Youssef Aboul-Enein
Amr Mohamed Badawey

Abstract

A comparative and stability-indicating reversed phase high performance liquid chromatographic study have been developed and validated for sitagliptin phosphate. The liquid chromatographic determination was achieved isocratically on Poroshell 120 EC-C18 (100 × 4.6 mm, i.d.; particle size, 2.7 µm), Pursuit 5PFP (150 × 4.6 mm, i.d.; particle size, 5 µm) and Chromolith performance RP-18e (100 × 4.6 mm, i.d.; macropore diameter, 2 µm) columns using a mobile phase consisting of methanol:water:triethylamine:acetic acid (60:40:0.1:0.1; v:v:v:v), at a flow rate 0.5 mL/min and UV detection at 268 nm. The method was linear over the concentration range of 100-1000 µg/mL (r = 0.9998) with a limit of detection and quantitation of 10 and 30 µg/mL, respectively. All the validation parameters and stability indicating study were studied on Poroshell 120 EC-C18 column, which achieved the best separation. The proposed method has been found to have the required accuracy, selectivity, sensitivity, and precision to assay sitagliptin phosphate in bulk form and in a pharmaceutical dosage form. Degradation products resulting from the stress studies did not interfere with the detection of sitagliptin phosphate that indicates that the assay are stability-indicating assay.


icon graph This Abstract was viewed 1715 times | icon graph Article PDF downloaded 928 times

How to Cite
(1)
Saleh, O. A.; El-Azzouny, A. A. E.-S.; Aboul-Enein, H. Y.; Badawey, A. M. A Validated Stability Indicating HPLC Method for Determination of Sitagliptin. Eur. J. Chem. 2014, 5, 497-502.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. Herman, G. A.; Stevens, C.; Dyck, K. V.; Bergman, A.; Yi, B.; De Smet, M.; Snyder, K.; Hilliard, D.; Tanen, M.; Tanaka, W.; Wang, A. Q.; Zeng, W.; Musson, D.; Winchell, G.; Davis, M. J.; Ramael, S.; Gottesdiener, K. M.; Wagner, J. Clin. Pharmacol. Ther. 2005, 78, 675-688.
http://dx.doi.org/10.1016/j.clpt.2005.09.002

[2]. Amori, R. E.; Lau, J.; Pittas, A. G. JAMA 2007, 298, 194-206.
http://dx.doi.org/10.1001/jama.298.2.194

[3]. Rosenstok, J.; Sankoh, S.; List, J. F. Diabetes Obes. Metab. 2008, 10, 376-386.
http://dx.doi.org/10.1111/j.1463-1326.2008.00876.x

[4]. Herman, G. A.; Bergman, A.; Liu, F.; Stevens, C.; Wang, A. Q.; Zeng, W.; Chen, L.; Snyder, K.; Hilliard, D.; Tanen, M.; Tanaka, W.; Meehan, A. G.; Lasseter, K.; Dilzer, S.; Blum, R.; Wagner, J. A. J. Clin. Pharmacol. 2006, 46, 876-886.
http://dx.doi.org/10.1177/0091270006289850

[5]. Eligar, V. S.; Bain, S. C. Drug Des. Dev. Ther. 2013, 7, 893-903.

[6]. Vincent, S. H.; Reed, J. R.; Bergman, A. J.; Elmore, C. S.; Zhu, B.; Xu, S.; Ebel, D.; Larson, P.; Zeng, W.; Chen, L.; Dilzer, S.; Lasseter, K.; Gottesdiener, K.; Wagner, J. A.; Herman, G. A. Drug Metab. Dispos. 2007, 35, 533-538.
http://dx.doi.org/10.1124/dmd.106.013136

[7]. Wei, Z.; Donald, G. M.; Alison, L. F.; Li, C.; Michael, S. S.; Eric, J. W.; Amy, Q. W. J. Pharmaceut. Biomed. 2008, 46, 534-542.
http://dx.doi.org/10.1016/j.jpba.2007.11.003

[8]. Ramakrishna, N.; Vishwottam, K.; Koteshwara, M.; Prashanth, K.; Raghupathi, A.; Rajeshkumar, B. Biomed. Chromatogr. 2008, 22, 214-222.
http://dx.doi.org/10.1002/bmc.926

[9]. Beconi, M. G.; Reed, J. R.; Teffera, Y.; Xia, Y. Q.; Kochansky, C. J.; Liu, D. Q.; Xu, S.; Elmore, C. S.; Ciccotto, S.; Hora, D. F.; Stearns, R. A.; Vincent, S. H. Drug Metab. Dispos. 2007, 35, 525-532.
http://dx.doi.org/10.1124/dmd.106.013110

[10]. Sekaran, C. B.; Prameela, R. Int. J. Pharm. Pharm. Sci. 2010, 2, 138-142.

[11]. Raja, T.; Rao, A. L. Int. J. Pharm. Chem. Biol. Sci. 2012, 2, 696-702.

[12]. Maste, M. M.; Parate, A. N.; Bhat, A. R. Asian J. Res. Chem. 2011, 4, 1466-1468.

[13]. Lavanya, R.; Yunoos, Md. J. Adv. Pharm. Edu. Res. 2013, 3, 475-479.

[14]. Pathan, H.; Sreenivas, R. T.; Chandanam, S.; Ashok, R.; Swetha, K. DHR Int. Pharm. Sci. 2014, 5, 80-87.

[15]. Moffat, A. C.; Osselten, M. D.; Widdop, B. Clarke's Analysis of Drugs and Poisons in Pharmaceuticals, Body Fluids and Post Mortem Material, 3rd Edn., Pharmaceuticals Press: London, 2004.

[16]. Clark, E. G. C. Clarke's Isolation and Identification of Drugs in Pharmaceuticals Body Fluids and post-Mortem Materials, 2nd Edn. The Pharmaceutical Press: London, 1986.

[17]. Hinchen, J. D. Practical Statistics for Chemical Research, 1st Edn. Methuen and Science Paperbacks, London, 1969.

Supporting Agencies

Most read articles by the same author(s)

Most read articles by the same author(s)

TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).